Results 231 to 240 of about 27,503 (257)

Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis

Therapeutic Advances in Endocrinology and Metabolism, 2021
Sanjay Kumar Bhadada, Mainak Banerjee, Soham Mukherjee   +2 more
exaly  

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Dipeptidyl peptidase 4 inhibitors

Reactions Weekly
openaire   +2 more sources

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga, Marie Aleth Richard, René Valero   +2 more
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes

Expert Opinion on Drug Safety, 2015
André Scheen
exaly  

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials

International Journal of Cardiology, 2016
Nathorn Chaiyakunapruk, Surakit Nathisuwan   +1 more
exaly  

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes

Postgraduate Medicine, 2013
André Scheen
exaly  

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

Expert Opinion on Investigational Drugs, 2004
Jens Juul Holst, Bo Ahrén, Carolyn F. Deacon   +2 more
exaly  

DIPEPTIDYL PEPTIDASE-4 INHIBITOR

2011
TOMINAGA YUJI, YOKOTA SHINICHI, TANAKA HOZUMI, KISHIDA HIDEYUKI, KITAGAWA MASAYASU, TACHI HIROSHI, OTA TORU   +6 more
openaire   +4 more sources